J&J Pays $1.5 Billion for Elan Stake

Published on Friday 03 July 2009 - 02:24

Summary :
J&J will buy an 18.4% stake in Irish biotech company Elan, in a bid to crack the potentially lucrative Alzheimer's market.
Read more

Information source

WSJ.com: What's News US

http://online.wsj.com

Website description
Business Financial News - The Wall Street Journal is the world's leading business publication. At WSJ.com users can access business news online as well as personal finance news

Articles published on this website : 0 / 7 days - 1 / 30 days

Work on Alzheimer Drug Halted Drug Makers Share Alzheimer's Data Caterpillar Gains, Pfizer Falls Alzheimer's Drug Falls Short When Alzheimer's Hits at 40

Other articles published on other websites on the same day

Lower risk of dementia for married or cohabiting people http://www.physorg.com/ Missing Alzheimer's Patient Found Safe In Alabama http://www.11alive.com/ Marital status and dementia risk http://www.nhs.uk/ Aerobic activity : Aerobic activity ‘helps keep brain young’ http://www.newspostonline.com/ Living Alone Increases Odds of Developing Dementia http://www.empowher.com/ Alzheimer’s Toxin Identified http://www.independent.com/ Dementia risk increases if living alone http://www.irishhealth.com/ Sunrise Senior Living to Launch Largest Ever Dementia Awareness Week Campaign http://www.pr-inside.com/ Congressional health committee gets reform bill down to $611 billion. Could Medicare reform add billions? — MedCity Morning Read, July 3, 2009 http://www.medcitynews.com/ Congressional health committee gets reform bill down to $611 billion. Could Medicare reform add billions? MedCity Morning Read, July 3, 2009 http://www.medcitynews.com/